Skip to content
★ Sign in to follow
KS

Kenneth S. Robinson

Executive
Oncternal Therapeutics, Inc.
Total declarations
44
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 02 Oct 2018 for Oncternal Therapeutics, Inc., €12k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Kenneth S. Robinson: trading record in brief

Kenneth S. Robinson is a declared insider of Oncternal Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 1 July 2008 to 1 October 2018, the count stands at 44 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The record was last updated on 2 October 2018 with a share grant (€12k) in Oncternal Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Kenneth S. Robinson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations32 total

25 of 32 declarations